The mesenchymal stem cell marker CD248 (Endosialin) is a negative regulator of bone formation in mice

Arthritis and Rheumatism

Volumn 64, Issue 10, 2012, Pages 3334-3343

  Naylor, Amy J ^a   Azzam, Eman ^b   Smith, Stuart ^a   Croft, Adam ^a   Poyser, Callum ^a   Duffield, Jeremy S ^c   Huso, David L ^d   Gay, Steffen ^e   Ospelt, Caroline ^e   Cooper, Mark S ^a   Isacke, Clare ^f   Goodyear, Simon R ^b   Rogers, Michael J ^b   Buckley, Christopher D ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

^c UNIVERSITY OF WASHINGTON   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^f INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; CALCEIN; ENDOSIALIN; GLYCEROL 2 PHOSPHATE; PLATELET DERIVED GROWTH FACTOR BB;

ANIMAL CELL; ARTICLE; BONE MASS; BONE MINERALIZATION; CELL PROLIFERATION; CONTROLLED STUDY; FEMUR; GENE DELETION; GENOTYPE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MESENCHYMAL STEM CELL; MICRO-COMPUTED TOMOGRAPHY; MORPHOMETRICS; MOUSE; NONHUMAN; OSSIFICATION; OSTEOARTHRITIS; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; TIBIA; WESTERN BLOTTING; WILD TYPE;

ANIMALS; ANTIGENS, CD; BONE AND BONES; CALCIFICATION, PHYSIOLOGIC; CELL PROLIFERATION; CELLS, CULTURED; HUMANS; MESENCHYMAL STROMAL CELLS; MICE; MICE, KNOCKOUT; NEOPLASM PROTEINS; OSTEOBLASTS; OSTEOGENESIS; PROTO-ONCOGENE PROTEINS C-SIS;

EID: 84869069949     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.34556     Document Type: Article

References (28)

1. Tomkowicz B, Rybinski K, Foley B, Ebel W, Kline B, Routhier E, et al. Interaction of endosialin/TEM1 with extracellular matrix proteins mediates cell adhesion and migration. Proc Natl Acad Sci U S A 2007; 104: 17965-70. (Pubitemid 350210804)
2. Lax S, Hardie D, Wilson A, Douglas M, Anderson G, Huso D, et al. The pericyte and stromal marker CD248 (endosialin) is required for efficient lymph node expansion. Eur J Immunol 2010; 40: 1884-9.
3. Bagley RG, Honma N, Weber W, Boutin P, Rouleau C, Shankara S, et al. Endosialin/TEM1/CD248 is a pericyte marker of embryonic and tumor neovascularisation. Microvasc Res 2008; 76: 180-8.
4. Smith SW, Eardley KS, Croft A, Nwosu J, Howie AJ, Cockwell P, et al. CD248-stromal cells are associated with progressive chronic kidney disease. Kidney Int 2011; 80: 199-207.
5. MacFadyen J, Savage K, Wienke D, Isacke CM. Endosialin is expressed on stromal fibroblasts and CNS pericytes in mouse embryos and is downregulated during development. Gene Expr Patterns 2007; 7: 363-9. (Pubitemid 44835271)
6. Maia M, de Vriese A, Janssens T, Moons M, van Landuyt K, Tavernier J, et al. CD248 and its cytoplasmic domain: a therapeutic target for arthritis. Arthritis Rheum 2010; 62: 3595-606.
7. Bagley RG, Weber W, Rouleau C, Yao M, Honma N, Kataoka S, et al. Human mesenchymal stem cells from bone marrow express tumor endothelial and stromal markers. Int J Oncol 2009;34: 619-27.
8. Nanda A, Karim B, Peng Z, Liu G, Qiu W, Gan C, et al. Tumor endothelial marker 1 (Tem1) functions in the growth and progression of abdominal tumors. Proc Natl Acad Sci U S A 2006;103: 3351-6. (Pubitemid 43346473)
9. Marty C, Langer-Machova Z, Sigrist S, Schott H, Schwendener RA, Ballmer-Hofer K. Isolation and characterization of a scFv antibody specific for tumor endothelial marker 1 (TEM1), a new reagent for targeted tumor therapy. Cancer Lett 2006;235: 298-308.
10. Su AL, Wiltshire T, Batalov S, Lapp H, Ching KA, Block D, et al. A gene atlas of mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci U S A 2004; 101: 6062-7. (Pubitemid 38520528)
11. Krempen K, Grotkopp D, Hall K, Bache A, Gillian A, Rippe RA, et al. Far upstream regulatory elements enhance positionindependent and uterus-specific expression of the murine -1(I) collagen promoter in transgenic mice. Gene Exp 1999; 8: 151-63. (Pubitemid 30013568)
12. Yata Y, Scanga A, Gillian A, Yang L, Reif S, Breindl M, et al. DNase 1-hypersensitive sites enhance -1(I) collagen gene expression in hepatic stellate cells. Hepatology 2003; 37: 267-76. (Pubitemid 36152525)
13. Huesa C, Yadav MC, Finnila MA, Goodyear SR, Robins SP, Tanner KE, et al. PHOSPHO1 is essential for mechanically competent mineralization and the avoidance of spontaneous fractures. Bone 2011; 48: 1066-74.
14. Somerville JM, Aspden RM, Armour KE, Armour KJ, Reid DM. Growth of C57Bl/6 mice and the material and mechanical properties of cortical bone from the tibia. Calcif Tissue Int 2004;74: 469-75. (Pubitemid 38623633)
15. MacFadyen JR, Haworth O, Roberston D, Hardie D, Webster MT, Morris HR, et al. Endosialin (TEM1, CD248) is a marker of stromal fibroblasts and is not selectively expressed on tumour endothelium. FEBS Lett 2005; 579: 2569-75. (Pubitemid 40615660)
16. Beamer WG, Donahue LR, Rosen CJ, Baylink DJ. Genetic variability in adult bone density among inbred strains of mice. Bone 1996; 18: 397-403. (Pubitemid 26152301)
17. Tomkowicz B, Rybinski K, Sebeck D, Sass P, Nicolaides NC, Grasso L, et al. Endosialin/TEM-1/CD248 regulates pericyte proliferation through PDGF receptor signaling. Cancer Biol Ther 2010; 9: 908-15.
18. Kose KN, Xie JF, Carnes DL, Graves DT. Pro-inflammatory cytokines downregulate platelet derived growth factor-receptor gene expression in human osteoblastic cells. J Cell Physiol 1996; 166:188-97. (Pubitemid 26017792)
19. Horner A, Bord S, Kemp P, Grainger D, Compston JE. Distribution of platelet-derived growth factor (PDGF) A chain mRNA, protein, and PDGF-receptor in rapidly forming human bone. Bone 1996; 19: 353-62. (Pubitemid 26370837)
20. Li L, Xie T. Stem cell niche: structure and function. Annu Rev Cell Dev Biol 2005; 21: 605-31. (Pubitemid 41740648)
21. Maes C, Kobayashi T, Selig MK, Torrekens S, Roth SI, Mackem S, et al. Osteoblast precursors, but not mature osteoblasts, move into developing and fractured bones along with invading blood vessels. Dev Cell 2010; 19: 329-44.
22. Sanchez-Fernandez MA, Gallois A, Riedl T, Jurdic P, Hoflack B. Osteoclasts control osteoblast chemotaxis via PDGF-BB/PDGF receptor - signaling. PLOS One 2008;3:e3537.
23. Gruber R, Karreth F, Kandler B, Fuerst G, Rot A, Fischer MB, et al. Platelet-released supernatants increase migration and proliferation, and decrease osteogenic differentiation of bone marrow-derived mesenchymal progenitor cells under in vitro conditions. Platelets 2004; 15: 29-35. (Pubitemid 38283218)
24. Sunters A, Thomas DP, Yeudall WA, Grigoriadis AE. Accelerated cell cycle progression in osteoblasts overexpressing the c-fos protooncogene. J Biol Chem 2004; 279: 9882-91.
25. Liu F, Malaval L, Aubin JE. The mature osteoblast phenotype is characterized by extensive plasticity. Exp Cell Res 1997;232: 97-105. (Pubitemid 27172224)
26. O'Sullivan S, Noat D, Callon K, Porteous F, Horne A, Wattie D, et al. Imatinib promotes osteoblast differentiation by inhibiting PDGFR signalling and inhibits osteoclastogenesis by both direct and stromal cell-dependent mechanisms. J Bone Miner Res 2007; 22:1679-89. (Pubitemid 351235134)
27. Fierro F, Illmer T, Jing D, Schleyer E, Ehninger G, Boxberger S, et al. Inhibition of platelet-derived growth factor receptor - by imatinib mesylate suppresses proliferation and alters differentiation of human mesenchymal stem cells in vitro. Cell Prolif 2007; 40: 355-66. (Pubitemid 46802187)
28. Tokunaga A, Oya T, Ishii Y, Motomura H, Nakamura C, Ishizawa S, et al. PDGF receptor - is a potent regulator of mesenchymal stromal cell function. J Bone Miner Res 2008; 23: 1519-27.